Nrf2 Nuclear factor-erythroid-2-related factor 2 the Curcuma longa active ingredient has at least 25 fold, at least 30 fold, at least 35 fold, at least 40 fold, at least 45 fold, at least 50 fold, at least 55 fold, at least 60 fold, at least 65 fold, at least 70 fold, at least 75 fold, at least 80 fold, at least 85 fold, at least 90 fold, at least 95 fold, at least 100 fold, at least 110 fold, at least 120 fold, at least 130 fold, at least 140 fold at least 150 fold, or at least 200 fold Nuclear factor-erythroid-2-related factor 2 (Nrf2) transcription factor-activating potential as compared to an untreated control
Multifaceted role of neuropilins in the immune system: potential targets for immunotherapy
SFN as well as metabolites of the pathway have been shown to have chemopreventive properties
While glutathione is included in the treatment of many diseases, its effects on them have not been definitively proven